Get the Stockscreener App
0.5342
1.71%
0.009
Veru Inc stock is traded at $0.5342, with a volume of 666.49K.
It is up +1.71% in the last 24 hours and up +7.70% over the past month.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
See More
Previous Close:
$0.5252
Open:
$0.5211
24h Volume:
666.49K
Relative Volume:
0.21
Market Cap:
$79.84M
Revenue:
$15.93M
Net Income/Loss:
$-64.59M
P/E Ratio:
-0.7123
EPS:
-0.75
Net Cash Flow:
$-59.50M
1W Performance:
+1.85%
1M Performance:
+7.70%
6M Performance:
-38.21%
1Y Performance:
-53.95%
1-Day Range:
$0.5207
$0.5398
1-Week Range:
$0.5061
$0.5767
52-Week Range:
$0.45
$1.75
Veru Inc Stock (VERU) Company Profile
Name
Veru Inc
Sector
Industry
Phone
(312) 595-9123
Address
2916 N. MIAMI AVENUE, MIAMI, FL
Compare VERU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERU
Veru Inc
|
0.5342 | 79.84M | 15.93M | -64.59M | -59.50M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Veru Inc Stock (VERU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-24 | Initiated | B. Riley Securities | Buy |
| Mar-28-24 | Initiated | Raymond James | Outperform |
| Jun-07-23 | Upgrade | Jefferies | Underperform → Hold |
| Apr-13-21 | Initiated | Jefferies | Buy |
| Feb-09-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-21-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-20-19 | Initiated | Oppenheimer | Outperform |
| Jul-03-18 | Initiated | Maxim Group | Buy |
View All
Veru Inc Stock (VERU) Latest News
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summi - GuruFocus
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit | VERU Stock News - GuruFocus
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit - GlobeNewswire
The Female Health Company Announces Board Changes - marketscreener.com
Veru Inc.'s (NASDAQ:VERU) 27% Price Boost Is Out Of Tune With Revenues - simplywall.st
DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Louisiana First News
Veru Insiders Miss 24% Gain After Offloading Stock - simplywall.st
What Do Wall Street Analysts Think About Veru Inc (NASDAQ: VERU) Stock? - stocksregister.com
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference - GlobeNewswire
Veru Sees Unusually Large Options Volume (NASDAQ:VERU) - MarketBeat
Veru Inc. (NASDAQ:VERU) Stock Position Boosted by Atria Investments Inc - Defense World
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Veru, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– VERU - Business Wire
Veru Inc. Shareholders Approve Equity Plan Amendment - TipRanks
VERU stock touches 52-week low at $0.47 amid market challenges - Investing.com Australia
VERU stock touches 52-week low at $0.47 amid market challenges By Investing.com - Investing.com South Africa
Here's Why Veru (VERU) Looks Ripe for Bottom Fishing - Yahoo Finance
Oppenheimer & Co. Inc. Boosts Stake in Veru Inc. (NASDAQ:VERU) - MarketBeat
B. Riley Cuts Price Target on Veru to $2 From $5, Keeps Buy Rating -March 07, 2025 at 07:49 am EST - Marketscreener.com
Veru Inc to Host Earnings Call - ACCESS Newswire
Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround - Yahoo Finance
VERU stock touches 52-week low at $0.49 amid market challenges - Investing.com Canada
Veru, Inc. to Host Earnings Call - ACCESS Newswire
Veru Inc. (NASDAQ:VERU) Director Acquires $52,403.45 in Stock - MarketBeat
Director Makes Bold Move with Major Veru Stock Purchase! - TipRanks
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Veru Inc. (VERU) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire
3 US Penny Stocks With Market Caps Under $300M To Consider - Simply Wall St
Veru Inc. director Michael Rankowitz buys $84,350 in common stock - Investing.com
Veru Inc. director Michael Rankowitz buys $84,350 in common stock By Investing.com - Investing.com South Africa
Short Interest in Veru Inc. (NASDAQ:VERU) Rises By 14.3% - MarketBeat
Veru (NASDAQ:VERU) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Veru (NASDAQ:VERU) Issues Earnings Results - MarketBeat
Veru Inc. Reports Fiscal 2025 First Quarter Financial Results and Clinical Program ProgressVERU INC. (NASDAQ: VERU) recently released its financial results for the first quarter of fiscal 2025, along with key updates on its clinical development progr - Defense World
Earnings call transcript: Veru Inc Q1 2025 beats EPS forecast, stock dips - MSN
Veru Inc. (NASDAQ:VERU) Short Interest Up 14.3% in January - Defense World
Oppenheimer Adjusts Price Target on Veru to $4 From $5, Keeps Outperform Rating - Marketscreener.com
Veru Inc. (NASDAQ:VERU) Q1 2025 Earnings Call Transcript - Insider Monkey
Veru Inc Faces Uncertain Financial Future Amidst Lack of Revenue and Regulatory Hurdles - TipRanks
Veru Inc Stock (VERU) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):